Ultrasound-Guided Stellate Ganglion Block With Botulinum

• Status: Not yet recruiting
• Trial end date: 2022-07-01
• Target enrollment: 0
• Participant gender: All

Summary

the local stellate ganglion block with bupivacaine and corticosteroid treatment for acute peripheral facial nerve palsy in patients can induce hyperglycemia, and an alternative local therapy may be necessary and some time may ve ineffective. Our purpose in this study is to evaluate therapeutic effects of stellate ganglion block (SGB) Botulinum Toxin on referactory facial nerve palsy

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University

Criteria

Inclusion Criteria:

• Diagnosed by clinical and neurological assessment as one-sided idiopathic facial palsy

• Age 18 to 60 •-ASA i-II

Exclusion Criteria:

• Exclusion Criteria:

• diabetic

• coagulation dysfunction

• mental or cognitive dysfunclion

• allergy to injected medication